TABLE 6-.
Baseline | 12-month | Baseline | 12-month | |
---|---|---|---|---|
LVEF (%) | 51.1± 9.4 | 59.2 ± 12.6t | 48.5 ± 8.2 | 55.7 ± 10.3t |
LVEDV (ml) | 156 ± 41 | 153 ± 44u | 155 ± 38 | 174 ± 46 |
LVESV (ml) | 78 ± 29 | 65 ± 34* | 79 ± 27 | 79 ± 36 |
Infarct Size (g) | 27.8 ± 15.6 | 15.5 ± 8.2** | 33.1 ± 18.7 | 19.2 ± 8.9** |
p < 0.05 vs. baseline LVESV;
p < 0.05 change in LVEDV from baseline to 12-months PostC vs. Control Group
p < 0.05 vs. Baseline LVEF
p < 0.01 vs. Baseline infarct size